RNAZ TRANSCODE THERAPEUTICS INC Delisting Actions 8-K Filing 2024 - Nasdaq Compliance Issues TransCode Therapeutics, Inc. received multiple deficiency letters from Nasdaq regarding non-compliance with minimum bid price and stockholders equity requirements, and is appealing the delisting decision with a hearing scheduled for October 1, 2024.Get access to all SEC 8-K filings of the TRANSCODE THERAPEUTICS INC